COVID Testing Kits

Kits and products designed to test an individual for the SARS-CoV-2 virus that is known to cause COVID-19; includes rapid tests, reagents, controls, stock, culture fluid, and other products.

181 – 195 of 460 results

181

Twist Bioscience SARS-COV-2 RNA CONTROL 2

Twist AR-S SARS-CoV-2 RNA Control 2(MN908947.3); Synthetic RNA control(103925)

Pricing & Availability

182

Genscript Corporation SARS-CoV-2 Spike 484Q Antibo

SARS-CoV-2 Spike (484Q) Antibody (Q8) mAb Mouse is specific for 484Q site of B 1 617 SARS-CoV-2 This product can recognize single mutant (E484Q) and double mutant (L452R E484Q) but can not recognize the wild type and single mutant (L452R)

Pricing & Availability

183

Genscript Corporation SARS-CoV-2 Spike protein S1 O

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases Recently the new B 1 1 529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant The B 1 1 529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern) named Omicron There are more than 30 mutations in the spike protein

Pricing & Availability

184

Genscript Corporation SARS-CoV-2 Nucleocapsid Protei

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) also known as 2019-nCoV is a positive-sense single-stranded RNA virus It caused coronavirus disease 2019 (COVID-19) Nucleocapsid Protein is the most abundant structural protein of the coronavirus which is associated with the nucleic acid The sublineage B 1 617 2 has been redesignated as a variant of concern (VOC-21APR-02) in May 2021 which spreads more quickly than the original version of the virus

Pricing & Availability

185

Genscript Corporation SARS-CoV-2 Spike N501 Neutra

The product is specific for N501 site of wild-type RBD For specific mutant protein the product recognizes wild-type RBD RBD single mutant (E484K) and RBD single mutant (K417N) but not recognizes RBD single mutant (N501Y) and RBD triple mutant (K417N E484K and N501Y) as seen in Figure 2

Pricing & Availability

186

Genscript Corporation cPass SARS-CoV-2 Neutralizati

The b GenScript SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit /b can detect circulating neutralizing antibodies against SARS-CoV-2 that block the interaction between the receptor binding domain of the viral spike glycoprotein (RBD) with the ACE2 cell surface receptor The assay detects any antibodies in serum and plasma that neutralize the RBD-ACE2 interaction The test is both species and isotype independent br/ br/ The b SARS-CoV-2 sVNT Kit /b is a blocking ELISA detection tool which mimics the virus neutralization process The kit contains two key components the Horseradish peroxidase (HRP) conjugated recombinant SARS-CoV-2 RBD fragment (HRP-RBD) and the human ACE2 receptor protein (hACE2) The protein-protein interaction between HRP-RBD and hACE2 can be blocked by neutralizing antibodies against SARS-CoV-2 RBD br/ First the samples and controls are pre-incubated with the HRP-RBD to allow the binding of the circulating neutralization antibodies to HRP-R